Literature DB >> 10344724

Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening.

W Horninger1, H Rogatsch, A Reissigl, H Volgger, H Klocker, A Hobisch, G Bartsch.   

Abstract

BACKGROUND: Measurement of percent free prostate-specific antigen (PSA), PSA density, and PSA-transition zone density (PSA-TZ density) in addition to total PSA is known to improve the specificity of PSA-based prostate cancer screening. We evaluated the ability of total PSA, percent free PSA, PSA density, and PSA-TZ density to predict pathologic features in radical prostatectomy specimens.
METHODS: The levels of total PSA, percent free PSA, PSA density, and PSA-TZ density assessed prior to the diagnosis of prostate cancer were correlated with the pathologic findings in 102 prostate glands with cancer obtained at radical prostatectomy. The entire organs were examined histologically; Pearson correlation coefficients were used for statistical analysis.
RESULTS: High levels of total PSA, PSA density, and PSA-TZ density correlated significantly with capsular penetration, high Gleason scores, and large cancer volumes in the prostatectomy specimens. Free PSA was found to correlate well with high Gleason scores, high percentages of cancer, and large cancer volumes, but not with capsular penetration. The four parameters were evaluated by means of logistic regression, which showed that only percent free PSA and total PSA were significant predictors of Gleason scores > or =7 and cancer volumes > or =0.5 cc. With regard to clinically insignificant cancers, only percent free PSA and the Gleason score obtained at biopsy were significant predictors.
CONCLUSIONS: In men whose prostate cancers are detected by PSA-based screening, high total PSA levels in combination with low percent free PSA levels are suggestive of a potentially more aggressive type of prostate cancer. This may help both patient and clinician in selecting the most appropriate therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344724     DOI: 10.1002/(sici)1097-0045(19990615)40:1<56::aid-pros7>3.0.co;2-e

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  4 in total

1.  PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancer.

Authors:  Stavros Sfoungaristos; Petros Perimenis
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

2.  The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database.

Authors:  Ryan S Turley; Martha K Terris; Christopher J Kane; William J Aronson; Joseph C Presti; Christopher L Amling; Stephen J Freedland
Journal:  BJU Int       Date:  2008-09-03       Impact factor: 5.588

3.  Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer.

Authors:  Mohammad Reza Nowroozi; Seyed Ali Momeni; Solmaz Ohadian Moghadam; Elnaz Ayati; Afshin Mortazavi; Simin Arfae; Hassan Jamshidian; Mohsen Taherimahmoudi; Mohsen Ayati
Journal:  Nephrourol Mon       Date:  2016-08-15

4.  Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy.

Authors:  Chao Peng; Jun Zhang; Jianquan Hou
Journal:  Cancer Manag Res       Date:  2019-02-01       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.